- finviz | 2022年08月16日 21:00Scilex Holding Company, a Sorrento Company, Announces Expanding Coverage to 30 Million Lives And Will Continue To Work To Access An Additional 20 Million Lives With One Of The Largest National Pharmacy Benefit Managers (PBMs) For ZTlido
- finviz | 2022年08月10日 21:01Health Check: How Prudently Does Sorrento Therapeutics (NASDAQ:SRNE) Use Debt?
- finviz | 2022年08月03日 21:00Sorrento Completes Successfully the SAD Study and Initiates the MAD Phase 1 Study with STI-1558, An Oral M(pro) Inhibitor as a Standalone Treatment and Prevention of COVID-19 without the Ritonavir as Booster
- finviz | 2022年07月30日 01:2910 Stocks to Sell Before They Die
- finviz | 2022年07月20日 23:10Sorrento (SRNE) Rises on FDA IND Clearance for COVID Drug
- finviz | 2022年07月20日 22:41FDA Clears Sorrento's STI-1558 Phase 1 Study To Treat COVID-19 Infection
- finviz | 2022年07月20日 02:53Sorrento Therapeutics Announces the FDA IND Clearance of STI-1558, An Oral M(pro) and Cathepsin L Inhibitor to Treat COVID-19
- finviz | 2022年07月15日 00:30Why Ocugen, Sorrento Therapeutics, and VBI Vaccines Are on the Move Today
- finviz | 2022年07月14日 18:15What Kind Of Investors Own Most Of Sorrento Therapeutics, Inc. (NASDAQ:SRNE)?
- finviz | 2022年07月07日 21:30Scilex Holding Company, a Sorrento Company, Has Entered A Term Sheet to Acquire Ancora Medical Inc.
- finviz | 2022年07月06日 02:04Scilex Holding Company, a Sorrento Company, announces that the Honorable Tommy G. Thompson has joined the Scilex Board of Directors
- finviz | 2022年07月05日 23:32Why Sorrento Therapeutics Stock Is Jumping Today
- finviz | 2022年06月25日 03:38Sorrento Therapeutics, Inc. announces the appointment of the Honorable Tommy G. Thompson, as Covid-19 Special Consultant to Chairman and CEO Henry Ji
- finviz | 2022年06月14日 22:33Scilex Holding Company, a Sorrento Company, enters into an agreement for an exclusive license with ROMEG Therapeutics, LLC, for the right to commercialize Gloperba
- finviz | 2022年06月11日 21:31Further weakness as Sorrento Therapeutics (NASDAQ:SRNE) drops 12% this week, taking one-year losses to 83%
- finviz | 2022年06月03日 21:20Sorrento Therapeutics Announces First Subject Dosed in a Phase I Clinical Study of STI-1558, an Oral Mpro Inhibitor as a Standalone Treatment and Prevention of COVID-19 Without Co-Administration of Ritonavir Booster